Payment overview · 2025
General Payments
$165.06
5 reported records · 4 companies
Healthcare provider profile · identity verified
Aleem Anthony Ali, M.D.
Allopathic & Osteopathic Physicians|Internal Medicine · WOODSIDE, NY · NPI 1497076129
Verified facts
What the public records show
CMS Open Payments records show Aleem Anthony Ali, M.D. received $165.06 in general payments during 2025 across 5 reported records.
ABBVIE INC. accounted for 40.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 7 associated products.
ABBVIE INC. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LINZESS as an associated drug or biological on 87954 records involving 21815 distinct recipient NPIs. Public Medicare Part D data also shows 25 claims for Linzess by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| ABBVIE INC. | Unresolved — no canonical attribution shown | $66.89 | 40.5% | 2 | 2025 |
| Kestra Medical Technology Services, Inc. | Unresolved — no canonical attribution shown | $49.36 | 29.9% | 1 | 2025 |
| Exact Sciences Corporation | Unresolved — no canonical attribution shown | $27.53 | 16.7% | 1 | 2025 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Unresolved — no canonical attribution shown | $21.28 | 12.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $165.06 | 5 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| EMBLAVEO Normalized: emblaveo |
Drug | ABBVIE INC. | $66.89 | 2 | 2025 |
Source payment records
|
|||||
| Assure WCD Normalized: assure wcd |
Device | Kestra Medical Technology Services, Inc. | $49.36 | 1 | 2025 |
Source payment records
|
|||||
| AVYCAZ Normalized: avycaz |
Drug | ABBVIE INC. | $33.27 | 1 | 2025 |
Source payment records
|
|||||
| DALVANCE Normalized: dalvance |
Drug | ABBVIE INC. | $33.27 | 1 | 2025 |
Source payment records
|
|||||
| TEFLARO Normalized: teflaro |
Drug | ABBVIE INC. | $33.27 | 1 | 2025 |
Source payment records
|
|||||
| The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit |
Device | Exact Sciences Corporation | $27.53 | 1 | 2025 |
Source payment records
|
|||||
| LifeVest Normalized: lifevest |
Device | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $21.28 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| ABBVIE INC. Exact reporting entity; no affiliate inference |
2025 | LINZESS open payments reported associated product |
CMS Open Payments — General Payments 87954 supporting records · 21815 recipient NPIs · example record 1201352608 |
Linzess · 2024 Exact normalized brand match · 1 Part D row |
25 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 690 | 292 |
| Amlodipine Besylate | Amlodipine Besylate | 545 | 184 |
| Eliquis | Apixaban | 392 | 101 |
| Gabapentin | Gabapentin | 323 | 131 |
| Losartan Potassium | Losartan Potassium | 299 | 117 |
| Levothyroxine Sodium | Levothyroxine Sodium | 297 | 98 |
| Tamsulosin Hcl | Tamsulosin Hcl | 278 | 117 |
| Metoprolol Tartrate | Metoprolol Tartrate | 239 | 70 |
| Metoprolol Succinate | Metoprolol Succinate | 235 | 96 |
| Furosemide | Furosemide | 226 | 82 |
| Metformin Hcl | Metformin Hcl | 214 | 91 |
| Oxycodone Hcl | Oxycodone Hcl | 207 | 56 |
| Clopidogrel | Clopidogrel Bisulfate | 186 | 58 |
| Lisinopril | Lisinopril | 179 | 48 |
| Donepezil Hcl | Donepezil Hcl | 168 | 46 |
| Escitalopram Oxalate | Escitalopram Oxalate | 168 | 47 |
| Tramadol Hcl | Tramadol Hcl | 168 | 47 |
| Hydralazine Hcl | Hydralazine Hcl | 167 | 53 |
| Pregabalin | Pregabalin | 155 | 22 |
| Divalproex Sodium | Divalproex Sodium | 147 | 34 |
| Levetiracetam | Levetiracetam | 147 | 35 |
| Latanoprost | Latanoprost | 138 | 42 |
| Finasteride | Finasteride | 131 | 46 |
| Mirtazapine | Mirtazapine | 130 | 44 |
| Xarelto | Rivaroxaban | 119 | 31 |
| Carvedilol | Carvedilol | 116 | 47 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 107 | 17 |
| Clotrimazole | Clotrimazole | 104 | 96 |
| Clonazepam | Clonazepam | 100 | 30 |
| Memantine Hcl | Memantine Hcl | 98 | 26 |
| Lactulose | Lactulose | 97 | 38 |
| Potassium Chloride | Potassium Chloride | 96 | 28 |
| Famotidine | Famotidine | 94 | 64 |
| Omeprazole | Omeprazole | 86 | 80 |
| Nifedipine Er | Nifedipine | 81 | 32 |
| Simvastatin | Simvastatin | 80 | 26 |
| Ammonium Lactate | Ammonium Lactate | 78 | 74 |
| Mupirocin | Mupirocin | 78 | 73 |
| Trazodone Hcl | Trazodone Hcl | 74 | 42 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 73 | 24 |
| Allopurinol | Allopurinol | 70 | 23 |
| Lorazepam | Lorazepam | 70 | 19 |
| Duloxetine Hcl | Duloxetine Hcl | 69 | 30 |
| Risperidone | Risperidone | 65 | 13 |
| Benztropine Mesylate | Benztropine Mesylate | 64 | suppressed |
| Lacosamide | Lacosamide | 63 | 18 |
| Montelukast Sodium | Montelukast Sodium | 62 | 26 |
| Alprazolam | Alprazolam | 61 | 16 |
| Entresto | Sacubitril/Valsartan | 61 | 13 |
| Hydrochlorothiazide | Hydrochlorothiazide | 61 | 31 |
| Quetiapine Fumarate | Quetiapine Fumarate | 59 | 17 |
| Spironolactone | Spironolactone | 59 | 22 |
| Januvia | Sitagliptin Phosphate | 58 | 14 |
| Midodrine Hcl | Midodrine Hcl | 57 | 17 |
| Insulin Lispro | Insulin Lispro | 55 | 15 |
| Olanzapine | Olanzapine | 55 | 15 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 54 | 18 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 52 | 21 |
| Sertraline Hcl | Sertraline Hcl | 51 | 26 |
| Pantoprazole Sodium | Pantoprazole Sodium | 50 | 19 |
| Citalopram Hbr | Citalopram Hydrobromide | 49 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 49 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 48 | 18 |
| Buspirone Hcl | Buspirone Hcl | 45 | 21 |
| Santyl | Collagenase Clostridium Hist. | 44 | 13 |
| Lithium Carbonate | Lithium Carbonate | 43 | suppressed |
| Procrit | Epoetin Alfa | 42 | suppressed |
| Prednisone | Prednisone | 41 | 22 |
| Amiodarone Hcl | Amiodarone Hcl | 40 | 13 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 39 | 13 |
| Digoxin | Digoxin | 38 | suppressed |
| Jardiance | Empagliflozin | 38 | 11 |
| Ketoconazole | Ketoconazole | 38 | 12 |
| Tradjenta | Linagliptin | 38 | suppressed |
| Anastrozole | Anastrozole | 37 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 37 | 13 |
| Labetalol Hcl | Labetalol Hcl | 37 | 11 |
| Nystatin | Nystatin | 37 | 22 |
| Timolol Maleate | Timolol Maleate | 36 | 11 |
| Retacrit | Epoetin Alfa-Epbx | 35 | suppressed |
| Methadone Hcl | Methadone Hcl | 33 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 31 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 30 | 22 |
| Sucralfate | Sucralfate | 30 | 16 |
| Alogliptin | Alogliptin Benzoate | 29 | 17 |
| Betamethasone Diprop Augmented | Betamethasone/Propylene Glyc | 29 | 29 |
| Brimonidine Tartrate | Brimonidine Tartrate | 29 | 12 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 29 | 28 |
| Hydromorphone Hcl | Hydromorphone Hcl | 29 | 11 |
| Amantadine | Amantadine Hcl | 28 | suppressed |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 28 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 28 | 25 |
| Sodium Chloride | 0.9 % Sodium Chloride | 28 | 13 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 28 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 28 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 27 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 26 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 26 | 15 |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 26 | suppressed |
| Topiramate | Topiramate | 26 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 25 | suppressed |
| Linzess | Linaclotide | 25 | suppressed |
| Torsemide | Torsemide | 25 | 13 |
| Ropinirole Hcl | Ropinirole Hcl | 24 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 24 | suppressed |
| Xifaxan | Rifaximin | 24 | suppressed |
| Baclofen | Baclofen | 23 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 23 | 12 |
| Piperacillin-Tazobactam | Piperacillin Sodium/Tazobactam | 23 | 13 |
| Clonidine Hcl | Clonidine Hcl | 22 | 11 |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 21 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 20 | suppressed |
| Methocarbamol | Methocarbamol | 20 | 16 |
| Bupropion Hcl | Bupropion Hcl | 19 | suppressed |
| Cinacalcet Hcl | Cinacalcet Hcl | 19 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 19 | 11 |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 19 | suppressed |
| Atenolol | Atenolol | 18 | 11 |
| Diltiazem Hcl | Diltiazem Hcl | 18 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 18 | suppressed |
| Loteprednol Etabonate | Loteprednol Etabonate | 18 | suppressed |
| Morphine Sulfate Er | Morphine Sulfate | 18 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 18 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 18 | 17 |
| Fluoxetine Hcl | Fluoxetine Hcl | 17 | suppressed |
| Ibuprofen | Ibuprofen | 17 | 17 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 17 | 13 |
| Metformin Hcl Er | Metformin Hcl | 17 | suppressed |
| Methotrexate | Methotrexate Sodium | 17 | suppressed |
| Nano 2nd Gen Pen Needle | Pen Needle, Diabetic | 17 | 17 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 17 | 13 |
| Carbamazepine Er | Carbamazepine | 16 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 16 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 16 | suppressed |
| Enoxaparin Sodium | Enoxaparin Sodium | 16 | suppressed |
| Lamotrigine | Lamotrigine | 16 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 16 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 16 | suppressed |
| Aripiprazole | Aripiprazole | 15 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 15 | suppressed |
| Austedo | Deutetrabenazine | 15 | suppressed |
| Levofloxacin | Levofloxacin | 15 | suppressed |
| Methenamine Hippurate | Methenamine Hippurate | 15 | suppressed |
| Methimazole | Methimazole | 15 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 15 | suppressed |
| Valsartan | Valsartan | 15 | suppressed |
| Xtandi | Enzalutamide | 15 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 14 | 13 |
| Budesonide | Budesonide | 14 | suppressed |
| Colchicine | Colchicine | 14 | suppressed |
| Fentanyl | Fentanyl | 14 | suppressed |
| Novolog Flexpen | Insulin Aspart | 14 | suppressed |
| Pilocarpine Hcl | Pilocarpine Hcl | 14 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 14 | suppressed |
| Tivicay | Dolutegravir Sodium | 14 | suppressed |
| Bupropion Xl | Bupropion Hcl | 13 | suppressed |
| Clonidine | Clonidine | 13 | suppressed |
| Diazepam | Diazepam | 13 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 13 | suppressed |
| Levemir | Insulin Detemir | 13 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 13 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 13 | suppressed |
| Admelog Solostar | Insulin Lispro | 12 | 12 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Clozapine | Clozapine | 12 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 12 | suppressed |
| Lurasidone Hcl | Lurasidone Hcl | 12 | suppressed |
| Tenofovir Disoproxil Fumarate | Tenofovir Disoproxil Fumarate | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Bumetanide | Bumetanide | 11 | suppressed |
| Dalfampridine Er | Dalfampridine | 11 | suppressed |
| Dextrose In Water | Dextrose 5 % In Water | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Gemtesa | Vibegron | 11 | suppressed |
| Haloperidol | Haloperidol | 11 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 11 | suppressed |
| Letrozole | Letrozole | 11 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 11 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 11 | suppressed |
| Primidone | Primidone | 11 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 11 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $165.06 · 5 records | ABBVIE INC. | AVYCAZ, Assure WCD, DALVANCE, EMBLAVEO, LifeVest, TEFLARO, The Cologuard Plus Collection Kit | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- How do you evaluate evidence when you have a financial relationship with ABBVIE INC.?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error